Blood Cancer UK Research

Blood Cancer UK Research funds research into blood cancers, covering fundamental disease processes, treatment options and innovative approaches to data use. Through its Project Grant scheme, it supports studies that improve understanding of disease mechanisms and develop personalised treatment options. The Clinical Improvement Programme funds project delivery and salaries with a focus on improving access to clinical trials. All funded research must be conducted in the UK. The charity has a particular interest in projects that demonstrate relevance, originality and innovation, clinical potential, feasibility and sustainability. Priority areas include improving understanding of fundamental disease processes, improving treatment options for the individual, and developing novel approaches to the use of data.

Blood Cancer UK Research only funds organisations, not individuals. Eligible applicants are UK-based research organisations such as universities, academic institutions and NHS bodies. The charity welcomes unsolicited applications. There are no religious restrictions. All funded research must be conducted in the UK and benefit the general public, particularly those living with blood cancers.

Through its Project Grant scheme, Blood Cancer UK Research does not fund biobank funding, bridging support between grants, or research involving randomised trials of clinical treatments. No other exclusions are specified for its Clinical Improvement Programme.

Blood Cancer UK Research offers multi-year project grants and a Clinical Improvement Programme that supports project delivery and salary costs. They welcome unsolicited applications and fund research that shows clinical potential, feasibility and sustainability. The charity supports both project costs and staff salaries through its programmes.